IP Library Granted Patent US 10,144,929
Granted Patent B2
US 10,144,929 · App. 15/426,455 · Granted Dec 4, 2018

Polypeptide inhibitors of Smad3 polypeptide activities

Inventors: Edward B. Leof (Rochester, MN); Mark C. Wilkes (Plainview, MN); Claire E. Repellin (Alameda, CA); Jeong-Han Kang (Rochester, MN); Xueqian Yin (Rochester, MN); Mahefatiana Andrianifahanana (Rochester, MN)
Assignee: Mayo Foundation for Medical Education and Research
C12N15/113A61K38/04A61K38/10A61K38/16C07K7/08C07K14/00C07K14/4702C07K14/4703C12N15/86C07K2319/10C12N2310/14C12N2310/531
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,144,929
App. No.
15/426,455
Granted
Dec 4, 2018
Kind
B2
Abstract

This document provides polypeptide inhibitors of Smad3 polypeptide activities. For example, methods and materials for using polypeptides (e.g., polypeptides designed to include both a cell penetrating amino acid sequence and an amino acid segment of a SH3 domain of a SNX9 polypeptide) to inhibit one or more Smad3 polypeptide activities are provided. This document also provides methods and materials for using RNA interference to treat a disease (e.g., a fibrotic disease) in a mammal (e.g., a human).

Claims (22)

1. A polypeptide comprising a cell penetrating amino acid sequence and an amino acid segment of a SH3 domain of a sorting nexin 9 (SNX9) polypeptide, wherein said amino acid segment is less than 45 amino acid residues in length and comprises the amino acid sequence set forth in SEQ ID NO:6 or 7.

2. The polypeptide of claim 1 , wherein said cell penetrating amino acid sequence comprises the amino acid sequence set forth in SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, or SEQ ID NO:5.

3. The polypeptide of claim 1 , wherein said polypeptide comprises the amino acid sequence set forth in any one of SEQ ID NOs:9, 11, 13-16, 18, 19, 21, 22, 24, and 25.

4. The polypeptide of claim 1 , wherein said amino acid segment comprises the amino acid sequence set forth in SEQ ID NO:6.

5. The polypeptide of claim 1 , wherein said amino acid segment comprises the amino acid sequence set forth in SEQ ID NO:7.

6. The polypeptide of claim 1 , wherein said cell penetrating amino acid sequence comprises the amino acid sequence set forth in SEQ ID NO:37.

7. The polypeptide of claim 1 , wherein said cell penetrating amino acid sequence comprises the amino acid sequence set forth in SEQ ID NO:2.

8. The polypeptide of claim 1 , wherein said cell penetrating amino acid sequence comprises the amino acid sequence set forth in SEQ ID NO:3.

9. The polypeptide of claim 1 , wherein said cell penetrating amino acid sequence comprises the amino acid sequence set forth in SEQ ID NO:4.

10. The polypeptide of claim 1 , wherein said cell penetrating amino acid sequence comprises the amino acid sequence set forth in SEQ ID NO:5.

11. The polypeptide of claim 1 , wherein said polypeptide comprises the amino acid sequence set forth in SEQ ID NO:9.

12. The polypeptide of claim 1 , wherein said polypeptide comprises the amino acid sequence set forth in SEQ ID NO:11.

13. The polypeptide of claim 1 , wherein said polypeptide comprises the amino acid sequence set forth in SEQ ID NO:13.

14. The polypeptide of claim 1 , wherein said polypeptide comprises the amino acid sequence set forth in SEQ ID NO:14.

15. The polypeptide of claim 1 , wherein said polypeptide comprises the amino acid sequence set forth in SEQ ID NO:15.

16. The polypeptide of claim 1 , wherein said polypeptide comprises the amino acid sequence set forth in SEQ ID NO:16.

17. The polypeptide of claim 1 , wherein said polypeptide comprises the amino acid sequence set forth in SEQ ID NO:18.

18. The polypeptide of claim 1 , wherein said polypeptide comprises the amino acid sequence set forth in SEQ ID NO:19.

19. The polypeptide of claim 1 , wherein said polypeptide comprises the amino acid sequence set forth in SEQ ID NO:21.

20. The polypeptide of claim 1 , wherein said polypeptide comprises the amino acid sequence set forth in SEQ ID NO:22.

21. The polypeptide of claim 1 , wherein said polypeptide comprises the amino acid sequence set forth in SEQ ID NO:24.

22. The polypeptide of claim 1 , wherein said polypeptide comprises the amino acid sequence set forth in SEQ ID NO:25.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2017
From: LEOF, EDWARD B.; WILKES, MARK C.; REPELLIN, CLAIRE E.; KANG, JEONG-HAN; YIN, XUEQIAN; ANDRIANIFAHANANA, MAHEFATIANA
To: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
Reel/Frame 043918/0468 →
Continuity (4)
Provisional Application 62354447 · Jun 24, 2016
Provisional Application 62297277 · Feb 19, 2016
Provisional Application 62295843 · Feb 16, 2016
Related Publication 20170253873A1 · Sep 7, 2017